EAM Investors’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-23,209
| Closed | -$2.11M | – | 371 |
|
|
2020
Q4 | $2.11M | Sell |
23,209
-12,951
| -36% | -$1.18M | 0.35% | 102 |
|
|
2020
Q3 | $1.45M | Sell |
36,160
-13,950
| -28% | -$557K | 0.34% | 120 |
|
|
2020
Q2 | $1.72M | Sell |
50,110
-17,537
| -26% | -$602K | 0.38% | 121 |
|
|
2020
Q1 | $1.5M | Buy |
+67,647
| New | +$1.5M | 0.47% | 101 |
|
|
2019
Q4 | – | Sell |
-38,540
| Closed | -$599K | – | 263 |
|
|
2019
Q3 | $599K | Sell |
38,540
-32,259
| -46% | -$501K | 0.16% | 223 |
|
|
2019
Q2 | $1.44M | Hold |
70,799
| – | – | 0.35% | 136 |
|
|
2019
Q1 | $1.24M | Sell |
70,799
-8,917
| -11% | -$157K | 0.31% | 152 |
|
|
2018
Q4 | $1.02M | Sell |
79,716
-2,027
| -2% | -$26K | 0.28% | 166 |
|
|
2018
Q3 | $1.33M | Buy |
81,743
+20,062
| +33% | +$327K | 0.2% | 181 |
|
|
2018
Q2 | $699K | Sell |
61,681
-217,480
| -78% | -$2.46M | 0.11% | 256 |
|
|
2018
Q1 | $2.73M | Buy |
+279,161
| New | +$2.73M | 0.45% | 113 |
|